TerrAscend (TSNDF) Income from Continuing Operations (2021 - 2026)

TerrAscend's (TSNDF) quarterly Income from Continuing Operations came in at 6829000.0 in Q1 2026, up 10.91% year-on-year from 6157426.77 in Q1 2025, and down 1233.79% on a QoQ basis from 512000.0 in Q4 2025.

TerrAscend (TSNDF) Income from Continuing Operations (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Income from Continuing Operations data on file, last reported at 6829000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 10.91% year-over-year to 6829000.0 in Q1 2026; TTM through Mar 2026 was 23654000.0, a 352.69% decrease from a year earlier, with the FY2025 full-year figure at 24489000.0, down 412.76% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 6829000.0, down from 512000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for TSNDF reached as high as 39147000.0 in Q4 2024 and fell as low as 300561000.0 in Q3 2022.
  • Historically, Income from Continuing Operations has averaged 21773117.65 across 5 years, with a median of 7665000.0 in 2025.
  • Across the five-year window, Income from Continuing Operations slumped 638.3% in 2022 and jumped 1410.88% in 2024, its largest moves.
  • Year by year, Income from Continuing Operations stood at 5666000.0 in 2022, then surged by 145.73% to 2591000.0 in 2023, then soared by 1410.88% to 39147000.0 in 2024, then tumbled by 101.31% to 512000.0 in 2025, then plunged by 1233.79% to 6829000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 6829000.0 in Q1 2026, 512000.0 in Q4 2025, and 9907000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn -6.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.83 Mn
Dec 31, 2025 -512,000.00
Sep 30, 2025 -9.91 Mn
Jun 30, 2025 -6.41 Mn
Mar 31, 2025 -7.67 Mn
Dec 31, 2024 39.15 Mn
Sep 30, 2024 -15.84 Mn
Jun 30, 2024 -6.29 Mn
Mar 31, 2024 -14.85 Mn
Dec 31, 2023 2.59 Mn
Sep 30, 2023 -8.44 Mn
Jun 30, 2023 -12.86 Mn
Mar 31, 2023 -19.18 Mn
Dec 31, 2022 -5.67 Mn
Sep 30, 2022 -300.56 Mn
Jun 30, 2022 16.86 Mn
Mar 31, 2022 -13.75 Mn
Dec 31, 2021 2.35 Mn
Sep 30, 2021 55.84 Mn
Jun 30, 2021 -29.66 Mn